Home › Categories › Health & Wellness› European Medicines Agency's Database

European Medicines Agency's Database.pdf

novorapid-epar-product-information_en.pdf

Preview of European Medicines Agency's database

🔗 Source: ema.europa.eu

📊 Size: 976 KB

👤 Author: CHMP

⬇️ Downloads: 180

Summary

NovoRapid is a rapid-acting insulin analogue for treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above. It is available in various forms, including vials, cartridges, and pre-filled pens. The dosage is individual and determined by the patient's needs, typically used in combination with intermediate-acting or long-acting insulin. Administration is subcutaneous, with injection sites rotated to reduce the risk of lipodystrophy and cutaneous amyloidosis. NovoRapid can also be used for continuous subcutaneous insulin infusion in pump systems and intravenous administration by healthcare staff.

Download File

Description

NovoRapid is a rapid-acting insulin analogue for treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above.

Technical Information

File Format: PDF
File Size: 976 KB
Pages: 122
Language: EN
Author: CHMP
Total Downloads: 180
Last Updated: 2 weeks ago

Document Overview

This PDF document about European Medicines Agency's database provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into European Medicines Agency's database.